All research papers

Dosimetry Data Infrastructure for Individualized Radiopharmaceutical Therapy: International Experience and a Proposed Framework for China.

Segment-based comparison of multiparametric MRI, Gallium-68-PSMA-PET/CT and combined imaging with histopathology in prostate cancer.

The Use of Radioactive Iodine in the Treatment of Thyroid Cancer: Novel Aspects.

Prevention and management of hormonal crisis in neuroendocrine tumors undergoing PRRT (peptide receptor radionuclide therapy): a systematic review.

THINKERS-X: multisequence MRI radiomics in a mixture-of-experts model for outcome prediction and exploratory dose-scenario evaluation in lung cancer brain metastases treated with radiosurgery.

PD-1/ PD-l1 Inhibitors and Stereotactic Radiosurgery for Brain Metastases: a systematic review and meta-analysis.

Surgical resection versus stereotactic body radiotherapy for oligometastatic breast cancer to the liver.

Production of ¹³⁵La via the ¹³⁶Ba(p,2n)¹³⁵La reaction and its DNA-damaging properties as a low-energy Auger electron emitter.

[¹⁷⁷Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.

Average annual occupational radiation exposure among dental staff: a 3-years retrospective observational study.

Patient-specific dosimetric impact of online adaptive radiotherapy for locally advanced cervical cancer.

Rethinking the limits: SRS for ≥20 brain metastases with favorable brain and hippocampal doses.

Radiotherapy combined with serplulimab, and chemotherapy as first-line treatment for metastatic pancreatic adenocarcinoma: a multicenter, single-arm, phase II trial.

Stereotactic body radiation therapy in elderly patients with spinal metastases.

DNA damage in thyroid cancer patients treated with radioactive iodine in Johannesburg, South Africa.

The Use and Utility of Preoperative Somatostatin Receptor-Based Imaging in Gastroenteropancreatic Neuroendocrine Tumors.

Is Eligibility Enough? Pretreatment Prediction of Failure to Reach a Second Cycle of [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy.

Uncertainty-Aware Simultaneous Synthesis and Segmentation Via Evidential Deep Learning.

Neoadjuvant Stereotactic Ablative Radiotherapy Before Inferior Vena Cava Thrombectomy for Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.

Interpretation of PlanIQ-derived feasibility dose-volume histogram f-values in lung SBRT with heterogeneous dose distributions.

Clinical translation of targeted alpha therapy: safety, dosimetry, radiation protection, and regulatory considerations.

Brain-Specific Quantification of Somatostatin Receptor Expression: SUV_max and SUVR_sss as Quantitative Correlates of the Krenning Score in Meningioma.

Radiopharmaceutical Therapy with [¹⁷⁷Lu]Lu-DOTATATE in Refractory Meningiomas: Results from the French Multicenter MELUTE Cohort.

Preclinical Evaluation on the Radiohybrid Tandem [¹⁸F]La- and [²²⁵Ac]Ac-rhPSMA-10.1 for Targeted α-Therapy of Prostate Cancer.

Multimodal Visual Question Answering System for Survival Prognosis in PSMA-Targeted Radiopharmaceutical Therapy.

Machine Learning Models Combining [⁶⁸Ga]Ga-PSMA-11 PET Radiomics and Clinical Features to Predict Overall Survival for Metastatic Castration-resistant Prostate Cancer Treated with [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy.

Radiation Dose to the Breast in Occupationally Exposed Healthcare Professionals: A Case Series.

Dosimetric comparison of the anisotropic analytical algorithm and Acuros XB for single-fraction cranial stereotactic radiosurgery with a 6 MV flattening filter-free beam.

Stereotactic Body Radiation Therapy for Management of Locally Advanced Periorbital Tumors: Efficacy and Toxicity Profile.

Artificial intelligence-assisted spatial correction of augmented reality projections; implementing radiation mapping during radioguided robotic surgery.

Transitioning from template-based groin dissection to dynamic sentinel node biopsy in penile cancer: Prospective validation of a standardization step.

Prognostic Value of Baseline High-Uptake PSMA Tumor Volume Fraction in Metastatic Castration-Resistant Prostate Cancer Patients Treated with [¹⁷⁷Lu]Lu-PSMA Radioligand Therapy.

A practical demand-based model for determining cyclotron irradiation time in routine 18F-FDG production.

Semi-Automated Image Labeling and Object Tracking for MR-Guided Radiotherapy Using a Foundation Vision Model.

End to end dosimetric and geometric verification of single isocenter multitarget stereotactic radiosurgery using an anthropomorphic phantom: external audit validation.

Comparative Outcomes of Stereotactic Radiosurgery and Surgical Resection for Radiation-Induced Meningiomas.

Integrated Multi-Time-Point ¹⁸F-FAPI PET/CT and Immune Histopathology for Predicting Pathological Complete Response in Microsatellite-Stable Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy, Chemotherapy, and Immunotherapy.

Unusual paraneoplastic thrombocytosis in small bowel neuroendocrine tumor responding to ¹⁷⁷Lu-DOTATATE.

Stereotactic body radiotherapy versus conventional external beam radiotherapy for bone metastases: a meta-analysis.

Pregnancy testing prior to iodine-131 thyroid therapy: a literature review of current recommendations.

A cohort electron blood self-dose fraction and its propagated uncertainty for ¹²⁴I PET pre-therapy dosimetry in radioiodine therapy of differentiated thyroid cancer.

¹⁷⁷Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from the Randomized Phase 2 LUNAR Trial.

Head-to-head comparison of ⁶⁸Ga-FAPI and ¹⁸F-FDG PET/CT in intracranial space-occupying lesions.

PSMA-targeted radioligand therapy in prostate cancer: evidence hierarchy, platform maturity of ¹⁷⁷Lu-PSMA-617, and the clinical differentiation challenge for emerging radionuclides.

CyberKnife Stereotactic Body Radiotherapy for Reirradiation of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Outcomes and Prognostic Factors.

Multibatch Analysis of Process Sensitivity Across Stages in 100 g Scale Mannose Triflate Synthesis.

Feasibility of reduced PTV margins in magnetic resonance image-guided online adaptive radiotherapy for bladder cancer: a personalised approach.

Uncertainty-aware auto-segmentation enables adaptive radiotherapy planning of liver metastases.

Integrated [⁶⁸Ga]Ga-FAPI-7ND PET/CT and stromal profiling of immunocompetent syngeneic tumor models for FAP-targeted radionuclide therapy.

Dosimetric Validation of Ethos Online Adaptive Radiotherapy for Prostate Cancer: An End-to-End Phantom Study.

Real-World PSA Response and Safety Outcomes of 177Lu-PSMA-617 in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective Validation Study.

cGMP production of radiometal solutions from solid targets at a university-scale facility.

Advancing infection imaging: A one-⁠step radioformulation strategy using antimicrobial peptide cold kit.

ACPSEM guideline: commissioning and quality assurance of Magnetic Resonance Imaging Linear Accelerators.

Detection rate of PSMA PET MRI (18 F-Flotufolastat) at the onset of biochemical recurrence following radical prostatectomy.

Sentinel lymph node-guided modification of postoperative radiotherapy in oral tongue squamous cell carcinoma: a retrospective dosimetric and NTCP modelling study.

Workflow-Based Radiation Protection During In-house 18F-FDG Production at a Hospital-based Cyclotron Facility.

Strategy Integrating Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors for Oligometastatic Non-Small Cell Lung Cancer: A Narrative Review.

Bone Radiopharmaceuticals: Evolution from Palliative Therapy to Targeted Precision Oncology and Theranostics.

68Ga-DOTATATE PET/CT Detection of Hypertrophic Osteoarthropathy in a Pediatric Patient With Neuroblastoma Following Anti-GD2 Immunotherapy.